Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Effects and mechanism of morroniside on osteogenic differentiation and proliferation of mouse MC3T3-E1 cells]. | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | 2022 | 35848187 | PubTator, text mining | PubMed |
| Identification of Key Non-coding RNAs and Transcription Factors in Calcific Aortic Valve Disease. | Front Cardiovasc Med | 2022 | 35845040 | PubTator, text mining | PubMed |
| Impact of Sr2+ and hypoxia on 3D triple cultures of primary human osteoblasts, osteocytes and osteoclasts. | Eur J Cell Biol | 2022 | 35839696 | PubTator, text mining | PubMed |
| ANGPTL4 regulates the osteogenic differentiation of periodontal ligament stem cells. | Funct Integr Genomics | 2022 | 35831768 | PubTator, text mining | PubMed |
| A novel lineage of osteoprogenitor cells with dual epithelial and mesenchymal properties govern maxillofacial bone homeostasis and regeneration after MSFL. | Cell Res | 2022 | 35821090 | PubTator, text mining | PubMed |
| Dental manifestation and management of hypophosphatasia. | Jpn Dent Sci Rev | 2022 | 35814738 | PubTator, text mining | PubMed |
| In vitro Exposure to Inflammatory Mediators Affects the Differentiation of Mesenchymal Progenitors. | Front Bioeng Biotechnol | 2022 | 35813997 | PubTator, text mining | PubMed |
| Biological Features of Extracellular Vesicles and Challenges. | Front Cell Dev Biol | 2022 | 35813192 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| TNFα activation and TGFβ blockage act synergistically for smooth muscle cell calcification in patients with venous thrombosis via TGFβ/ERK pathway. | J Cell Mol Med | 2022 | 35808901 | PubTator, text mining | PubMed |
| Mn-Containing Bioactive Glass-Ceramics: BMP-2-Mimetic Peptide Covalent Grafting Boosts Human-Osteoblast Proliferation and Mineral Deposition. | Materials (Basel) | 2022 | 35806763 | PubTator, text mining | PubMed |
| 3D Spheroid Human Dermal Papilla Cell as an Effective Model for the Screening of Hair Growth Promoting Compounds: Examples of Minoxidil and 3,4,5-Tri-O-caffeoylquinic acid (TCQA). | Cells | 2022 | 35805177 | PubTator, text mining | PubMed |
| Osteoblasts in a Perfusion Flow Bioreactor-Tissue Engineered Constructs of TiO2 Scaffolds and Cells for Improved Clinical Performance. | Cells | 2022 | 35805079 | PubTator, text mining | PubMed |
| Mechanosensitive Hydrolysis of ATP and ADP in Lamina Propria of the Murine Bladder by Membrane-Bound and Soluble Nucleotidases. | Front Physiol | 2022 | 35784885 | PubTator, text mining | PubMed |
| Combined Preimplantation Genetic Testing for Genetic Kidney Disease: Genetic Risk Identification, Assisted Reproductive Cycle, and Pregnancy Outcome Analysis. | Front Med (Lausanne) | 2022 | 35783601 | PubTator, text mining | PubMed |
| In vitro characterization of iridoid and phenylethanoid glycosides from Cistanche phelypaea for nutraceutical and pharmacological applications. | Phytother Res | 2022 | 35781895 | PubTator, text mining | PubMed |
| Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations. | Osteoporos Int | 2022 | 35776147 | PubTator, text mining | PubMed |
| Regulation and dysregulation of hair regeneration: aiming for clinical application. | Cell Regen | 2022 | 35773427 | PubTator, text mining | PubMed |
| Function-specific IL-17A and dexamethasone interactions in primary human airway epithelial cells. | Sci Rep | 2022 | 35773318 | PubTator, text mining | PubMed |
| Biomineralization associated alkaline phosphatase as a potential marker of bone metastasis in the patients with invasive breast cancer. | Saudi J Biol Sci | 2022 | 35770272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=42